Is a Low-Density Lipoprotein (LDL) level of 107 milligrams per deciliter and a High-Density Lipoprotein (HDL) level of 117 milligrams per deciliter considered good or bad in a 70-year-old female patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a 70-year-old female patient, an LDL of 107 mg/dL and HDL of 117 mg/dL represents a generally favorable lipid profile, suggesting good cardiovascular protection. The LDL level is near optimal, as guidelines suggest an LDL-C <100 mg/dL for women, especially those at high risk 1. However, a level of 107 mg/dL is close to this ideal and may not necessitate immediate pharmacological intervention unless other risk factors are present. The HDL level is exceptionally good, well above the recommended minimum of 50 mg/dL for women 1, which helps remove LDL cholesterol from the bloodstream, reducing plaque buildup in arteries.

Key Considerations:

  • The patient's lipid profile indicates a low risk of cardiovascular disease based solely on LDL and HDL levels.
  • Lifestyle interventions, such as a diet rich in fruits, vegetables, whole grains, and healthy fats, along with regular physical activity, are crucial for maintaining heart health 1.
  • The high HDL level (117 mg/dL) is beneficial and likely reflects genetic factors and/or very healthy lifestyle habits.
  • Regular monitoring of lipid levels should continue as part of routine healthcare to assess the need for any future interventions.

Recommendations:

  • Continue to emphasize heart-healthy habits, including a balanced diet and regular physical activity 1.
  • Avoid smoking and limit exposure to environmental tobacco smoke 1.
  • Maintain a healthy weight and body mass index (BMI) through a balance of physical activity and caloric intake 1.
  • Consider screening for depression, especially if the patient has a history of cardiovascular disease 1, as part of comprehensive care.

Given the current lipid profile and assuming the absence of other significant risk factors or cardiovascular diseases, no immediate pharmacological intervention for LDL lowering is recommended based solely on the provided lipid values. However, regular follow-up and monitoring of cardiovascular risk factors are essential to guide any future management decisions 1.

From the Research

Lipid Profile Evaluation

  • The patient's lipid profile shows an LDL (low-density lipoprotein) level of 107 and an HDL (high-density lipoprotein) level of 117 2.
  • According to the study, the primary therapeutic goal is to lower LDL cholesterol, and the treatment of dyslipidemias plays a major role in the primary and secondary prevention of cardiovascular disease 2.

LDL and HDL Levels

  • An LDL level of 107 is considered relatively high, and the goal of treatment is to achieve an LDL-cholesterol level adequate to the patient's cardiovascular risk through lifestyle modification and, if necessary, medication 2.
  • An HDL level of 117 is considered high, and high HDL levels are associated with a lower risk of cardiovascular disease 3, 4.

Treatment and Management

  • Statin therapy has been shown to be effective in lowering LDL levels and increasing HDL levels in patients with different cardiovascular diseases 3.
  • The study suggests that pitavastatin, a type of statin, can increase HDL levels and improve the quality and functionality of HDL particles 4.
  • Lifestyle modification and patient engagement in disease prevention are also important for managing the lipid profile of coronary heart disease patients 5.

Clinical Implications

  • The standard lipid profile has been shown to be effective in reducing coronary heart disease, but it has limitations in estimating LDL cholesterol and LDL particle risk in size and concentration 6.
  • Further studies are needed to compare the benefit of targeting LDL particle concentration and size versus ever lower LDL cholesterol concentration 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lipid Profile and Lipoprotein(a) Testing.

Deutsches Arzteblatt international, 2023

Research

Managing the lipid profile of coronary heart disease patients.

Expert review of cardiovascular therapy, 2016

Research

Standard lipid profile.

Clinics in laboratory medicine, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.